| 0 |
PROVIDENCIA URINARY TRACT INFECTION |
1 |
0.5000 |
| 1 |
MALE REPRODUCTIVE TRACT NEOPLASM |
1 |
0.1667 |
| 2 |
CIRCULATING ANTICOAGULANT |
2 |
0.1053 |
| 3 |
COELIAC ARTERY ANEURYSM |
1 |
0.0417 |
| 4 |
BONE DEMINERALISATION |
44 |
0.0415 |
| 5 |
RETIREMENT |
1 |
0.0400 |
| 6 |
NEPHROANGIOSCLEROSIS |
6 |
0.0373 |
| 7 |
PERITONEAL DIALYSATE LEAKAGE |
1 |
0.0303 |
| 8 |
FEMORAL NERVE INJURY |
2 |
0.0278 |
| 9 |
KARYOTYPE ANALYSIS ABNORMAL |
3 |
0.0275 |
| 10 |
CONGENITAL HIV INFECTION |
1 |
0.0256 |
| 11 |
VIRAL LOAD ABNORMAL |
4 |
0.0229 |
| 12 |
JOINT DISLOCATION POSTOPERATIVE |
1 |
0.0222 |
| 13 |
FEAR-RELATED AVOIDANCE OF ACTIVITIES |
3 |
0.0197 |
| 14 |
PLASMA CELL DISORDER |
1 |
0.0196 |
| 15 |
HIV ASSOCIATED NEPHROPATHY |
1 |
0.0196 |
| 16 |
HIV-ASSOCIATED NEUROCOGNITIVE DISORDER |
2 |
0.0180 |
| 17 |
TOXIC NEUROPATHY |
7 |
0.0178 |
| 18 |
SEDATIVE THERAPY |
1 |
0.0175 |
| 19 |
EXPLORATORY OPERATION |
2 |
0.0155 |
| 20 |
MUSCULOSKELETAL PROCEDURAL COMPLICATION |
1 |
0.0152 |
| 21 |
VIRAL LOAD INCREASED |
53 |
0.0136 |
| 22 |
FAT REDISTRIBUTION |
3 |
0.0129 |
| 23 |
SOCIOECONOMIC PRECARITY |
2 |
0.0116 |
| 24 |
INFUSION SITE STREAKING |
1 |
0.0115 |
| 25 |
MAY-THURNER SYNDROME |
2 |
0.0112 |
| 26 |
TUBERCULOMA OF CENTRAL NERVOUS SYSTEM |
2 |
0.0110 |
| 27 |
NATURAL KILLER CELL COUNT DECREASED |
1 |
0.0109 |
| 28 |
PULMONARY AMYLOIDOSIS |
1 |
0.0109 |
| 29 |
EXCESSIVE EXERCISE |
1 |
0.0105 |
| 30 |
T-LYMPHOCYTE COUNT DECREASED |
7 |
0.0103 |
| 31 |
BLOOD HIV RNA INCREASED |
18 |
0.0099 |
| 32 |
INTESTINAL CONGESTION |
1 |
0.0096 |
| 33 |
ANHEDONIA |
251 |
0.0095 |
| 34 |
POEMS SYNDROME |
1 |
0.0095 |
| 35 |
CD4 LYMPHOCYTES ABNORMAL |
2 |
0.0095 |
| 36 |
CANCER IN REMISSION |
2 |
0.0083 |
| 37 |
INCARCERATED INGUINAL HERNIA |
1 |
0.0082 |
| 38 |
PNEUMOCOCCAL BACTERAEMIA |
1 |
0.0079 |
| 39 |
CHORIORETINITIS |
5 |
0.0078 |
| 40 |
CD19 LYMPHOCYTES DECREASED |
1 |
0.0077 |
| 41 |
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION |
2 |
0.0072 |
| 42 |
MYOMECTOMY |
1 |
0.0070 |
| 43 |
PLEUROPERITONEAL COMMUNICATION |
1 |
0.0070 |
| 44 |
OROPHARYNGEAL SQUAMOUS CELL CARCINOMA |
1 |
0.0069 |
| 45 |
SYPHILIS |
5 |
0.0069 |
| 46 |
BLOOD TRIGLYCERIDES ABNORMAL |
6 |
0.0068 |
| 47 |
VIRAEMIA |
9 |
0.0065 |
| 48 |
OSTEOMALACIA |
10 |
0.0065 |
| 49 |
GLOMERULOSCLEROSIS |
4 |
0.0063 |
| 50 |
ELECTROCARDIOGRAM QT INTERVAL ABNORMAL |
3 |
0.0060 |
| 51 |
FANCONI SYNDROME ACQUIRED |
10 |
0.0057 |
| 52 |
FOETAL HEART RATE DECELERATION ABNORMALITY |
4 |
0.0057 |
| 53 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
6 |
0.0056 |
| 54 |
DRUG RESISTANCE MUTATION |
1 |
0.0056 |
| 55 |
CD4 LYMPHOCYTES DECREASED |
12 |
0.0056 |
| 56 |
HYPEREOSINOPHILIC SYNDROME |
3 |
0.0055 |
| 57 |
ECONOMIC PROBLEM |
84 |
0.0055 |
| 58 |
CYSTITIS RADIATION |
1 |
0.0052 |
| 59 |
CD8 LYMPHOCYTES DECREASED |
1 |
0.0050 |
| 60 |
PERIORBITAL DISORDER |
1 |
0.0049 |
| 61 |
PSEUDOCELLULITIS |
1 |
0.0047 |
| 62 |
VIROLOGIC FAILURE |
25 |
0.0046 |
| 63 |
VIRAL MUTATION IDENTIFIED |
17 |
0.0046 |
| 64 |
SEXUALLY TRANSMITTED DISEASE |
2 |
0.0046 |
| 65 |
END STAGE RENAL DISEASE |
83 |
0.0045 |
| 66 |
OSTEOPENIA |
69 |
0.0045 |
| 67 |
FOREARM FRACTURE |
3 |
0.0043 |
| 68 |
RENAL CORTICAL NECROSIS |
1 |
0.0043 |
| 69 |
CD4 LYMPHOCYTES INCREASED |
1 |
0.0043 |
| 70 |
GLOMERULONEPHRITIS MEMBRANOUS |
5 |
0.0043 |
| 71 |
LIPIDS ABNORMAL |
3 |
0.0041 |
| 72 |
BODY MASS INDEX ABNORMAL |
1 |
0.0041 |
| 73 |
DYSLIPIDAEMIA |
20 |
0.0039 |
| 74 |
RECTAL NEOPLASM |
1 |
0.0038 |
| 75 |
HYPERTENSIVE NEPHROPATHY |
4 |
0.0037 |
| 76 |
EYELID OPERATION |
1 |
0.0037 |
| 77 |
FACIAL WASTING |
1 |
0.0037 |
| 78 |
HEPATITIS B SURFACE ANTIGEN POSITIVE |
1 |
0.0036 |
| 79 |
EXCESSIVE SKIN |
1 |
0.0035 |
| 80 |
RENAL TUBULAR DYSFUNCTION |
2 |
0.0035 |
| 81 |
CONTRAINDICATED DRUG PRESCRIBED |
1 |
0.0035 |
| 82 |
PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT |
3 |
0.0034 |
| 83 |
BREAST ENGORGEMENT |
1 |
0.0034 |
| 84 |
LIPODYSTROPHY ACQUIRED |
7 |
0.0033 |
| 85 |
SITTING DISABILITY |
2 |
0.0032 |
| 86 |
HYPERPARATHYROIDISM SECONDARY |
8 |
0.0032 |
| 87 |
BREAST HAEMORRHAGE |
1 |
0.0030 |
| 88 |
NEPHROGENIC ANAEMIA |
14 |
0.0030 |
| 89 |
ACUTE HEPATITIS B |
1 |
0.0030 |
| 90 |
QUALITY OF LIFE DECREASED |
40 |
0.0030 |
| 91 |
DECREASED ACTIVITY |
32 |
0.0030 |
| 92 |
WAIST CIRCUMFERENCE INCREASED |
3 |
0.0029 |
| 93 |
EOSINOPHILIC FASCIITIS |
1 |
0.0029 |
| 94 |
URETEROLITHIASIS |
3 |
0.0029 |
| 95 |
PATHOGEN RESISTANCE |
26 |
0.0028 |
| 96 |
MICROSPORIDIA INFECTION |
1 |
0.0028 |
| 97 |
GLOMERULAR FILTRATION RATE ABNORMAL |
4 |
0.0028 |
| 98 |
ESCHERICHIA URINARY TRACT INFECTION |
12 |
0.0028 |
| 99 |
CHRONIC KIDNEY DISEASE |
204 |
0.0027 |
| 100 |
BONE DENSITY DECREASED |
83 |
0.0026 |
| 101 |
FAT TISSUE DECREASED |
1 |
0.0026 |
| 102 |
HEARING DISABILITY |
1 |
0.0026 |
| 103 |
PANCREATOLITHIASIS |
1 |
0.0025 |
| 104 |
TINEA PEDIS |
4 |
0.0025 |
| 105 |
SHOULDER FRACTURE |
4 |
0.0024 |
| 106 |
BIOPSY LIVER |
1 |
0.0024 |
| 107 |
ENDOMETRIAL DISORDER |
1 |
0.0024 |
| 108 |
AORTIC VALVE REPLACEMENT |
3 |
0.0024 |
| 109 |
HEPATITIS A |
2 |
0.0024 |
| 110 |
MICTURITION DISORDER |
8 |
0.0023 |
| 111 |
THALAMUS HAEMORRHAGE |
2 |
0.0023 |
| 112 |
PROSTATITIS |
7 |
0.0023 |
| 113 |
EMOTIONAL DISTRESS |
278 |
0.0023 |
| 114 |
MITOCHONDRIAL CYTOPATHY |
1 |
0.0023 |
| 115 |
DEGENERATIVE BONE DISEASE |
1 |
0.0023 |
| 116 |
OSTEOPOROSIS |
92 |
0.0022 |
| 117 |
BODY MASS INDEX INCREASED |
3 |
0.0022 |
| 118 |
ANAEMIA OF CHRONIC DISEASE |
2 |
0.0022 |
| 119 |
RENAL TRANSPLANT |
8 |
0.0022 |
| 120 |
MONONEUROPATHY MULTIPLEX |
1 |
0.0022 |
| 121 |
GALLBLADDER RUPTURE |
1 |
0.0022 |
| 122 |
GASTROINTESTINAL STOMA OUTPUT INCREASED |
1 |
0.0021 |
| 123 |
INTENSIVE CARE |
3 |
0.0021 |
| 124 |
LIPOATROPHY |
2 |
0.0021 |
| 125 |
INFUSION SITE HAEMATOMA |
1 |
0.0021 |
| 126 |
FAT TISSUE INCREASED |
3 |
0.0021 |
| 127 |
GENOTYPE DRUG RESISTANCE TEST POSITIVE |
2 |
0.0019 |
| 128 |
ACQUIRED IMMUNODEFICIENCY SYNDROME |
1 |
0.0019 |
| 129 |
SKIN CANDIDA |
1 |
0.0019 |
| 130 |
HYPERLIPASAEMIA |
1 |
0.0019 |
| 131 |
HEPATITIS B REACTIVATION |
6 |
0.0019 |
| 132 |
COATING IN MOUTH |
1 |
0.0019 |
| 133 |
INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION |
1 |
0.0019 |
| 134 |
FRACTURE PAIN |
1 |
0.0019 |
| 135 |
BODY FAT DISORDER |
1 |
0.0018 |
| 136 |
INTERTRIGO |
1 |
0.0018 |
| 137 |
MORNING SICKNESS |
1 |
0.0018 |
| 138 |
NEPHROPATHY |
17 |
0.0018 |
| 139 |
LIFE SUPPORT |
1 |
0.0018 |
| 140 |
BURNING MOUTH SYNDROME |
1 |
0.0018 |
| 141 |
MULTIPLE FRACTURES |
29 |
0.0018 |
| 142 |
COLLAGEN DISORDER |
1 |
0.0017 |
| 143 |
SELF-INJURIOUS IDEATION |
7 |
0.0017 |
| 144 |
ARTERIOVENOUS FISTULA SITE COMPLICATION |
1 |
0.0017 |
| 145 |
SLEEP TERROR |
7 |
0.0017 |
| 146 |
HIV INFECTION |
5 |
0.0017 |
| 147 |
PALATAL DISORDER |
1 |
0.0017 |
| 148 |
HYPERTENSIVE HEART DISEASE |
3 |
0.0016 |
| 149 |
OESOPHAGEAL ATRESIA |
1 |
0.0016 |
| 150 |
NEUROPATHIC ARTHROPATHY |
1 |
0.0015 |
| 151 |
VITAMIN D DEFICIENCY |
15 |
0.0015 |
| 152 |
PROTEIN TOTAL ABNORMAL |
2 |
0.0015 |
| 153 |
SHORT-BOWEL SYNDROME |
1 |
0.0015 |
| 154 |
PROTEINURIA |
29 |
0.0015 |
| 155 |
HIV TEST POSITIVE |
1 |
0.0015 |
| 156 |
PERSONAL RELATIONSHIP ISSUE |
1 |
0.0015 |
| 157 |
HEPATITIS B DNA INCREASED |
1 |
0.0015 |
| 158 |
HEAD AND NECK CANCER |
1 |
0.0015 |
| 159 |
HYPERURICAEMIA |
6 |
0.0015 |
| 160 |
HYPERPARATHYROIDISM |
3 |
0.0015 |
| 161 |
ANGULAR CHEILITIS |
1 |
0.0014 |
| 162 |
HYPOSPADIAS |
3 |
0.0014 |
| 163 |
LATENT TUBERCULOSIS |
3 |
0.0014 |
| 164 |
ALANINE AMINOTRANSFERASE ABNORMAL |
3 |
0.0014 |
| 165 |
ALPHA 1 FOETOPROTEIN INCREASED |
1 |
0.0014 |
| 166 |
CERVICAL RADICULOPATHY |
1 |
0.0014 |
| 167 |
GLOMERULAR FILTRATION RATE DECREASED |
17 |
0.0014 |
| 168 |
TEMPERATURE REGULATION DISORDER |
3 |
0.0013 |
| 169 |
ENTEROVESICAL FISTULA |
1 |
0.0013 |
| 170 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
2 |
0.0013 |
| 171 |
NEPHROTIC SYNDROME |
9 |
0.0013 |
| 172 |
ARTERIAL RUPTURE |
1 |
0.0013 |
| 173 |
HAEMANGIOMA |
3 |
0.0013 |
| 174 |
INFUSION SITE INFECTION |
3 |
0.0013 |
| 175 |
SKIN NEOPLASM EXCISION |
1 |
0.0013 |
| 176 |
LABORATORY TEST INTERFERENCE |
1 |
0.0013 |
| 177 |
TOOTH LOSS |
26 |
0.0013 |
| 178 |
HERPES ZOSTER DISSEMINATED |
1 |
0.0012 |
| 179 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 180 |
INTERCEPTED PRODUCT DISPENSING ERROR |
2 |
0.0012 |
| 181 |
RESUSCITATION |
2 |
0.0012 |
| 182 |
STRESS CARDIOMYOPATHY |
7 |
0.0012 |
| 183 |
CONTRAINDICATED PRODUCT PRESCRIBED |
2 |
0.0012 |
| 184 |
ENZYME LEVEL INCREASED |
1 |
0.0012 |
| 185 |
KIDNEY FIBROSIS |
2 |
0.0012 |
| 186 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
55 |
0.0011 |
| 187 |
PARVOVIRUS B19 INFECTION |
1 |
0.0011 |
| 188 |
HEART TRANSPLANT |
1 |
0.0011 |
| 189 |
SKIN WRINKLING |
3 |
0.0011 |
| 190 |
SELECTIVE EATING DISORDER |
1 |
0.0011 |
| 191 |
DRUG LEVEL ABOVE THERAPEUTIC |
5 |
0.0011 |
| 192 |
SPINAL COMPRESSION FRACTURE |
9 |
0.0011 |
| 193 |
PRODUCT APPEARANCE CONFUSION |
1 |
0.0011 |
| 194 |
PREMATURE MENOPAUSE |
1 |
0.0011 |
| 195 |
ENDOTRACHEAL INTUBATION |
3 |
0.0011 |
| 196 |
PULPITIS DENTAL |
1 |
0.0011 |
| 197 |
FOOT FRACTURE |
20 |
0.0011 |
| 198 |
OSTEOPOROTIC FRACTURE |
2 |
0.0010 |
| 199 |
PARTNER STRESS |
1 |
0.0010 |
| 200 |
INFUSION SITE NODULE |
1 |
0.0010 |
| 201 |
VASCULAR GRAFT |
3 |
0.0010 |
| 202 |
HYPERVIGILANCE |
1 |
0.0010 |
| 203 |
LOW DENSITY LIPOPROTEIN INCREASED |
8 |
0.0010 |
| 204 |
ANAL CANCER |
1 |
0.0010 |
| 205 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
2 |
0.0010 |
| 206 |
RENAL TUBULAR NECROSIS |
10 |
0.0010 |
| 207 |
RESPIRATORY ACIDOSIS |
4 |
0.0010 |
| 208 |
PYURIA |
1 |
0.0010 |
| 209 |
RENAL CYST |
8 |
0.0010 |
| 210 |
PRODUCT DOSE OMISSION ISSUE |
296 |
0.0010 |
| 211 |
HIGH DENSITY LIPOPROTEIN INCREASED |
1 |
0.0010 |
| 212 |
ANXIETY |
285 |
0.0010 |
| 213 |
ANTISOCIAL BEHAVIOUR |
1 |
0.0010 |
| 214 |
CREATININE RENAL CLEARANCE DECREASED |
4 |
0.0010 |
| 215 |
GASTRECTOMY |
1 |
0.0010 |
| 216 |
HEPATITIS B |
6 |
0.0010 |
| 217 |
RENAL FAILURE |
132 |
0.0010 |
| 218 |
AUTONOMIC NEUROPATHY |
1 |
0.0010 |
| 219 |
EAR HAEMORRHAGE |
2 |
0.0010 |
| 220 |
BLOOD CREATININE INCREASED |
64 |
0.0010 |
| 221 |
CAROTID ARTERIOSCLEROSIS |
1 |
0.0010 |
| 222 |
FOETAL DEATH |
5 |
0.0010 |
| 223 |
CARPAL TUNNEL DECOMPRESSION |
1 |
0.0009 |
| 224 |
PANCREATIC MASS |
1 |
0.0009 |
| 225 |
BONE LOSS |
14 |
0.0009 |
| 226 |
GALLBLADDER ENLARGEMENT |
1 |
0.0009 |
| 227 |
GASTRIC BYPASS |
2 |
0.0009 |
| 228 |
RENAL TUBULAR ACIDOSIS |
2 |
0.0009 |
| 229 |
RENAL IMPAIRMENT |
77 |
0.0009 |
| 230 |
INFUSION SITE HAEMORRHAGE |
3 |
0.0009 |
| 231 |
BIPOLAR I DISORDER |
2 |
0.0009 |
| 232 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
3 |
0.0009 |
| 233 |
NEPHROSCLEROSIS |
1 |
0.0009 |
| 234 |
FEAR OF DEATH |
2 |
0.0009 |
| 235 |
DYSLEXIA |
1 |
0.0009 |
| 236 |
PALMAR ERYTHEMA |
1 |
0.0009 |
| 237 |
REACTION TO EXCIPIENT |
2 |
0.0009 |
| 238 |
MUCOSAL HAEMORRHAGE |
1 |
0.0009 |
| 239 |
RALES |
5 |
0.0009 |
| 240 |
NECK SURGERY |
2 |
0.0009 |
| 241 |
TIBIA FRACTURE |
4 |
0.0009 |
| 242 |
DIALYSIS |
12 |
0.0008 |
| 243 |
ANKLE FRACTURE |
13 |
0.0008 |
| 244 |
RECTAL PROLAPSE |
1 |
0.0008 |
| 245 |
RENAL TUBULAR INJURY |
1 |
0.0008 |
| 246 |
INTERVERTEBRAL DISC OPERATION |
1 |
0.0008 |
| 247 |
GASTROINTESTINAL TUBE INSERTION |
2 |
0.0008 |
| 248 |
DISSEMINATED TUBERCULOSIS |
2 |
0.0008 |
| 249 |
SKELETAL INJURY |
8 |
0.0008 |
| 250 |
RETINAL DEGENERATION |
1 |
0.0008 |
| 251 |
LIBIDO DISORDER |
1 |
0.0008 |
| 252 |
ACQUIRED GENE MUTATION |
1 |
0.0008 |
| 253 |
GLYCOSURIA |
1 |
0.0007 |
| 254 |
EFFUSION |
1 |
0.0007 |
| 255 |
RIB FRACTURE |
15 |
0.0007 |
| 256 |
RENAL ARTERY STENOSIS |
1 |
0.0007 |
| 257 |
SOCIAL PROBLEM |
3 |
0.0007 |
| 258 |
ATYPICAL MYCOBACTERIAL INFECTION |
1 |
0.0007 |
| 259 |
GENITAL RASH |
1 |
0.0007 |
| 260 |
DUODENAL ULCER HAEMORRHAGE |
2 |
0.0007 |
| 261 |
EXERCISE TOLERANCE DECREASED |
4 |
0.0007 |
| 262 |
FIBULA FRACTURE |
2 |
0.0007 |
| 263 |
HYPERTONIC BLADDER |
2 |
0.0007 |
| 264 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
1 |
0.0007 |
| 265 |
TOOTH INJURY |
3 |
0.0007 |
| 266 |
BLOOD CREATINE INCREASED |
3 |
0.0007 |
| 267 |
NEPHRECTOMY |
1 |
0.0007 |
| 268 |
MENTAL FATIGUE |
1 |
0.0007 |
| 269 |
LOSS OF EMPLOYMENT |
2 |
0.0007 |
| 270 |
RENAL PAIN |
7 |
0.0007 |
| 271 |
ABDOMINAL HERNIA |
3 |
0.0007 |
| 272 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 273 |
DAYDREAMING |
1 |
0.0006 |
| 274 |
GASTROSTOMY |
1 |
0.0006 |
| 275 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 276 |
GASTROINTESTINAL STOMA COMPLICATION |
1 |
0.0006 |
| 277 |
INTESTINAL ULCER |
1 |
0.0006 |
| 278 |
RENAL DISORDER |
29 |
0.0006 |
| 279 |
HYPERCHOLESTEROLAEMIA |
6 |
0.0006 |
| 280 |
FRUSTRATION TOLERANCE DECREASED |
5 |
0.0006 |
| 281 |
RENAL INJURY |
18 |
0.0006 |
| 282 |
INABILITY TO AFFORD MEDICATION |
6 |
0.0006 |
| 283 |
PROTEIN URINE PRESENT |
3 |
0.0006 |
| 284 |
EDUCATIONAL PROBLEM |
1 |
0.0006 |
| 285 |
GASTRIC DILATATION |
1 |
0.0006 |
| 286 |
LAZINESS |
1 |
0.0006 |
| 287 |
FEMORAL NECK FRACTURE |
3 |
0.0006 |
| 288 |
POLYNEUROPATHY |
7 |
0.0006 |
| 289 |
PERIPHERAL COLDNESS |
8 |
0.0006 |
| 290 |
AMYLOIDOSIS |
1 |
0.0006 |
| 291 |
HEPATITIS C |
7 |
0.0006 |
| 292 |
ACUTE KIDNEY INJURY |
88 |
0.0006 |
| 293 |
FOOD INTERACTION |
1 |
0.0006 |
| 294 |
PANCREATIC FAILURE |
1 |
0.0006 |
| 295 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
5 |
0.0006 |
| 296 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 297 |
SCLERODERMA |
2 |
0.0005 |
| 298 |
DRUG RESISTANCE |
14 |
0.0005 |
| 299 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 300 |
BONE DENSITY ABNORMAL |
2 |
0.0005 |
| 301 |
ARTERIOSCLEROSIS |
5 |
0.0005 |
| 302 |
PERONEAL NERVE PALSY |
3 |
0.0005 |
| 303 |
DEPRESSION |
120 |
0.0005 |
| 304 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 305 |
CLAVICLE FRACTURE |
2 |
0.0005 |
| 306 |
GINGIVAL RECESSION |
1 |
0.0005 |
| 307 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 308 |
FOOD ALLERGY |
4 |
0.0005 |
| 309 |
CONVERSION DISORDER |
1 |
0.0005 |
| 310 |
IMPAIRED WORK ABILITY |
11 |
0.0005 |
| 311 |
DYSSTASIA |
15 |
0.0005 |
| 312 |
CYTOMEGALOVIRUS CHORIORETINITIS |
1 |
0.0005 |
| 313 |
PYELONEPHRITIS ACUTE |
1 |
0.0005 |
| 314 |
JOINT NOISE |
1 |
0.0005 |
| 315 |
PROSTATOMEGALY |
2 |
0.0005 |
| 316 |
THERAPY CHANGE |
5 |
0.0005 |
| 317 |
PAIN |
312 |
0.0005 |
| 318 |
DIPLEGIA |
1 |
0.0005 |
| 319 |
GENE MUTATION |
1 |
0.0005 |
| 320 |
PRODUCT DISPENSING ERROR |
11 |
0.0005 |
| 321 |
AZOTAEMIA |
2 |
0.0005 |
| 322 |
CARDIAC DISCOMFORT |
1 |
0.0005 |
| 323 |
LIBIDO INCREASED |
1 |
0.0005 |
| 324 |
BREAST DISORDER |
1 |
0.0005 |
| 325 |
OSTEONECROSIS |
16 |
0.0005 |
| 326 |
POLYCYTHAEMIA |
1 |
0.0005 |
| 327 |
INTERNATIONAL NORMALISED RATIO FLUCTUATION |
1 |
0.0005 |
| 328 |
WEIGHT FLUCTUATION |
5 |
0.0005 |
| 329 |
INFUSION SITE SWELLING |
3 |
0.0005 |
| 330 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 331 |
INFUSION SITE PAIN |
6 |
0.0005 |
| 332 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 333 |
JAW FRACTURE |
1 |
0.0005 |
| 334 |
OESOPHAGEAL VARICES HAEMORRHAGE |
1 |
0.0005 |
| 335 |
DIABETIC NEPHROPATHY |
1 |
0.0005 |
| 336 |
COLONOSCOPY |
1 |
0.0005 |
| 337 |
DANDRUFF |
1 |
0.0005 |
| 338 |
RENAL COLIC |
1 |
0.0004 |
| 339 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 340 |
LICHENOID KERATOSIS |
1 |
0.0004 |
| 341 |
FLAT AFFECT |
1 |
0.0004 |
| 342 |
FEELING OF DESPAIR |
2 |
0.0004 |
| 343 |
PATELLA FRACTURE |
1 |
0.0004 |
| 344 |
HYPERKALAEMIA |
15 |
0.0004 |
| 345 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
1 |
0.0004 |
| 346 |
VENTRICULAR TACHYCARDIA |
7 |
0.0004 |
| 347 |
INGROWING NAIL |
1 |
0.0004 |
| 348 |
POISONING DELIBERATE |
4 |
0.0004 |
| 349 |
GAIT INABILITY |
14 |
0.0004 |
| 350 |
OXYGEN CONSUMPTION INCREASED |
1 |
0.0004 |
| 351 |
RADIUS FRACTURE |
1 |
0.0004 |
| 352 |
HUMERUS FRACTURE |
2 |
0.0004 |
| 353 |
NEPHROLITHIASIS |
19 |
0.0004 |
| 354 |
RASH VESICULAR |
2 |
0.0004 |
| 355 |
BURSITIS |
5 |
0.0004 |
| 356 |
COELIAC DISEASE |
4 |
0.0004 |
| 357 |
DECREASED IMMUNE RESPONSIVENESS |
4 |
0.0004 |
| 358 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
2 |
0.0004 |
| 359 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 360 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 361 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 362 |
ABNORMAL UTERINE BLEEDING |
1 |
0.0004 |
| 363 |
LIPOMA |
1 |
0.0004 |
| 364 |
HERNIA REPAIR |
1 |
0.0004 |
| 365 |
POLLAKIURIA |
16 |
0.0004 |
| 366 |
FOLLICULITIS |
4 |
0.0004 |
| 367 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 368 |
GASTROINTESTINAL MOTILITY DISORDER |
2 |
0.0004 |
| 369 |
FOOD POISONING |
2 |
0.0004 |
| 370 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 371 |
FRACTURE |
7 |
0.0004 |
| 372 |
CHONDROPATHY |
1 |
0.0004 |
| 373 |
ASTHENOPIA |
2 |
0.0004 |
| 374 |
RHINALGIA |
1 |
0.0004 |
| 375 |
BONE PAIN |
21 |
0.0004 |
| 376 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 377 |
RENAL TUBULAR DISORDER |
1 |
0.0004 |
| 378 |
UPPER LIMB FRACTURE |
7 |
0.0004 |
| 379 |
LIP PAIN |
1 |
0.0003 |
| 380 |
MOBILITY DECREASED |
25 |
0.0003 |
| 381 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 382 |
DYSPNOEA AT REST |
1 |
0.0003 |
| 383 |
EOSINOPHILIA |
6 |
0.0003 |
| 384 |
NEGATIVE THOUGHTS |
1 |
0.0003 |
| 385 |
LIVER DISORDER |
15 |
0.0003 |
| 386 |
EXPOSURE DURING PREGNANCY |
21 |
0.0003 |
| 387 |
RHABDOMYOLYSIS |
14 |
0.0003 |
| 388 |
WRIST FRACTURE |
4 |
0.0003 |
| 389 |
MOUTH ULCERATION |
7 |
0.0003 |
| 390 |
OROPHARYNGEAL DISCOMFORT |
3 |
0.0003 |
| 391 |
BONE MARROW DISORDER |
1 |
0.0003 |
| 392 |
BONE DISORDER |
6 |
0.0003 |
| 393 |
NEURALGIA |
8 |
0.0003 |
| 394 |
MASTICATION DISORDER |
1 |
0.0003 |
| 395 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 396 |
HEPATOTOXICITY |
7 |
0.0003 |
| 397 |
HEPATIC CYTOLYSIS |
4 |
0.0003 |
| 398 |
LIVER ABSCESS |
1 |
0.0003 |
| 399 |
OEDEMA MOUTH |
1 |
0.0003 |
| 400 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 401 |
PRODUCT FORMULATION ISSUE |
2 |
0.0003 |
| 402 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 403 |
DIABETES MELLITUS |
23 |
0.0003 |
| 404 |
SKIN INJURY |
1 |
0.0003 |
| 405 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 406 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 407 |
TYPE 2 DIABETES MELLITUS |
10 |
0.0003 |
| 408 |
NEUROPATHY PERIPHERAL |
28 |
0.0003 |
| 409 |
INTERNATIONAL NORMALISED RATIO ABNORMAL |
1 |
0.0003 |
| 410 |
HYPERTENSION |
61 |
0.0003 |
| 411 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 412 |
PRODUCT STORAGE ERROR |
25 |
0.0003 |
| 413 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 414 |
HAND FRACTURE |
2 |
0.0003 |
| 415 |
PROSTATE CANCER STAGE IV |
1 |
0.0003 |
| 416 |
PRODUCT USE ISSUE |
53 |
0.0003 |
| 417 |
APPENDICECTOMY |
1 |
0.0003 |
| 418 |
INTERCEPTED PRODUCT STORAGE ERROR |
1 |
0.0003 |
| 419 |
HIP FRACTURE |
9 |
0.0003 |
| 420 |
GOUT |
5 |
0.0003 |
| 421 |
BACK INJURY |
3 |
0.0003 |
| 422 |
SEPTIC SHOCK |
12 |
0.0003 |
| 423 |
SEBORRHOEA |
1 |
0.0003 |
| 424 |
GAIT DISTURBANCE |
52 |
0.0003 |
| 425 |
CEREBRAL DISORDER |
2 |
0.0003 |
| 426 |
NEPHROPATHY TOXIC |
3 |
0.0003 |
| 427 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 428 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 429 |
CONTRAINDICATED PRODUCT ADMINISTERED |
8 |
0.0003 |
| 430 |
MUSCULOSKELETAL DISORDER |
5 |
0.0003 |
| 431 |
GASTRIC INFECTION |
1 |
0.0003 |
| 432 |
PRODUCT DOSE OMISSION |
17 |
0.0003 |
| 433 |
NIGHTMARE |
9 |
0.0003 |
| 434 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 435 |
TREATMENT NONCOMPLIANCE |
14 |
0.0003 |
| 436 |
OESOPHAGEAL PAIN |
1 |
0.0003 |
| 437 |
GINGIVAL PAIN |
2 |
0.0003 |
| 438 |
HYPERLIPIDAEMIA |
3 |
0.0003 |
| 439 |
METABOLIC ACIDOSIS |
8 |
0.0002 |
| 440 |
MUSCLE HAEMORRHAGE |
1 |
0.0002 |
| 441 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 442 |
PRODUCT DOSE OMISSION IN ERROR |
7 |
0.0002 |
| 443 |
HYPERGLYCAEMIA |
9 |
0.0002 |
| 444 |
RECURRENT CANCER |
1 |
0.0002 |
| 445 |
DEMYELINATION |
1 |
0.0002 |
| 446 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 447 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 448 |
LEG AMPUTATION |
1 |
0.0002 |
| 449 |
HEMIPLEGIA |
2 |
0.0002 |
| 450 |
CANDIDA INFECTION |
4 |
0.0002 |
| 451 |
WEIGHT INCREASED |
53 |
0.0002 |
| 452 |
LIP OEDEMA |
1 |
0.0002 |
| 453 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 454 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 455 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 456 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 457 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
4 |
0.0002 |
| 458 |
LIVER FUNCTION TEST INCREASED |
5 |
0.0002 |
| 459 |
SKIN HYPERPIGMENTATION |
2 |
0.0002 |
| 460 |
MUSCLE STRAIN |
2 |
0.0002 |
| 461 |
FAECES DISCOLOURED |
5 |
0.0002 |
| 462 |
SUICIDAL IDEATION |
21 |
0.0002 |
| 463 |
INTERVERTEBRAL DISC PROTRUSION |
5 |
0.0002 |
| 464 |
DYSPHEMIA |
1 |
0.0002 |
| 465 |
INTENTIONAL DEVICE MISUSE |
1 |
0.0002 |
| 466 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 467 |
TRANSAMINASES INCREASED |
5 |
0.0002 |
| 468 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 469 |
ELECTROCARDIOGRAM QT PROLONGED |
8 |
0.0002 |
| 470 |
OPTIC NEURITIS |
2 |
0.0002 |
| 471 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 472 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 473 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 474 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 475 |
DYSURIA |
8 |
0.0002 |
| 476 |
ABNORMAL DREAMS |
6 |
0.0002 |
| 477 |
EYE OPERATION |
1 |
0.0002 |
| 478 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 479 |
AGRANULOCYTOSIS |
4 |
0.0002 |
| 480 |
ANAEMIA |
41 |
0.0002 |
| 481 |
DRUG INTERACTION |
34 |
0.0002 |
| 482 |
FLANK PAIN |
2 |
0.0002 |
| 483 |
ANGINA PECTORIS |
6 |
0.0002 |
| 484 |
HYPERSOMNIA |
6 |
0.0002 |
| 485 |
LOWER LIMB FRACTURE |
4 |
0.0002 |
| 486 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 487 |
RENAL CELL CARCINOMA |
1 |
0.0002 |
| 488 |
DYSPEPSIA |
20 |
0.0002 |
| 489 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 490 |
IMMUNODEFICIENCY |
3 |
0.0002 |
| 491 |
ANEURYSM |
1 |
0.0002 |
| 492 |
HIP ARTHROPLASTY |
3 |
0.0002 |
| 493 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 494 |
TREATMENT FAILURE |
16 |
0.0002 |
| 495 |
NERVOUS SYSTEM DISORDER |
6 |
0.0002 |
| 496 |
CATATONIA |
1 |
0.0002 |
| 497 |
HEAD INJURY |
6 |
0.0002 |
| 498 |
INCONTINENCE |
2 |
0.0002 |
| 499 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 500 |
RETCHING |
4 |
0.0002 |
| 501 |
JOINT INJURY |
4 |
0.0002 |
| 502 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 503 |
BALANCE DISORDER |
16 |
0.0002 |
| 504 |
NORMAL NEWBORN |
1 |
0.0002 |
| 505 |
MENTAL DISORDER |
8 |
0.0002 |
| 506 |
PULMONARY THROMBOSIS |
2 |
0.0002 |
| 507 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 508 |
TOOTH FRACTURE |
2 |
0.0002 |
| 509 |
DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0002 |
| 510 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 511 |
FOOT DEFORMITY |
2 |
0.0002 |
| 512 |
LEUKOPENIA |
9 |
0.0002 |
| 513 |
SKIN DISORDER |
6 |
0.0002 |
| 514 |
NERVE INJURY |
2 |
0.0002 |
| 515 |
ALANINE AMINOTRANSFERASE INCREASED |
11 |
0.0002 |
| 516 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 517 |
OCULAR DISCOMFORT |
2 |
0.0002 |
| 518 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 519 |
SCAB |
2 |
0.0002 |
| 520 |
CHOLECYSTECTOMY |
2 |
0.0002 |
| 521 |
EXTRA DOSE ADMINISTERED |
7 |
0.0002 |
| 522 |
METABOLIC DISORDER |
1 |
0.0002 |
| 523 |
BACK PAIN |
40 |
0.0002 |
| 524 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 525 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 526 |
ENERGY INCREASED |
1 |
0.0002 |
| 527 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 528 |
INSOMNIA |
45 |
0.0002 |
| 529 |
SINUS HEADACHE |
1 |
0.0002 |
| 530 |
SKIN EXFOLIATION |
14 |
0.0002 |
| 531 |
CONDITION AGGRAVATED |
50 |
0.0002 |
| 532 |
HAEMORRHAGE |
17 |
0.0002 |
| 533 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 534 |
HEPATIC ENZYME INCREASED |
11 |
0.0002 |
| 535 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 536 |
TOOTH EXTRACTION |
2 |
0.0002 |
| 537 |
FATIGUE |
125 |
0.0002 |
| 538 |
DYSPNOEA EXERTIONAL |
6 |
0.0002 |
| 539 |
MULTIPLE INJURIES |
1 |
0.0002 |
| 540 |
FLATULENCE |
9 |
0.0002 |
| 541 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 542 |
FEELING JITTERY |
3 |
0.0002 |
| 543 |
MOOD SWINGS |
5 |
0.0002 |
| 544 |
GLAUCOMA |
3 |
0.0002 |
| 545 |
ERECTILE DYSFUNCTION |
4 |
0.0002 |
| 546 |
PRESCRIBED OVERDOSE |
3 |
0.0002 |
| 547 |
INCOHERENT |
1 |
0.0002 |
| 548 |
RASH GENERALISED |
4 |
0.0002 |
| 549 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
8 |
0.0002 |
| 550 |
NODULE |
2 |
0.0002 |
| 551 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 552 |
POLYP |
1 |
0.0002 |
| 553 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 554 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 555 |
BLOOD PRESSURE ABNORMAL |
3 |
0.0002 |
| 556 |
APPETITE DISORDER |
1 |
0.0002 |
| 557 |
BLOOD CHOLESTEROL INCREASED |
7 |
0.0002 |
| 558 |
SPINAL FRACTURE |
3 |
0.0001 |
| 559 |
HOSPITALISATION |
23 |
0.0001 |
| 560 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 561 |
FEAR |
4 |
0.0001 |
| 562 |
PRODUCT PHYSICAL ISSUE |
3 |
0.0001 |
| 563 |
LOSS OF CONSCIOUSNESS |
19 |
0.0001 |
| 564 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
5 |
0.0001 |
| 565 |
MUSCLE SPASMS |
27 |
0.0001 |
| 566 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 567 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 568 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 569 |
MATERNAL EXPOSURE DURING PREGNANCY |
13 |
0.0001 |
| 570 |
LARGE INTESTINE POLYP |
1 |
0.0001 |
| 571 |
FORMICATION |
1 |
0.0001 |
| 572 |
DEMENTIA |
4 |
0.0001 |
| 573 |
CARPAL TUNNEL SYNDROME |
2 |
0.0001 |
| 574 |
BURNING SENSATION |
10 |
0.0001 |
| 575 |
HYPOAESTHESIA |
21 |
0.0001 |
| 576 |
HYPERTHYROIDISM |
2 |
0.0001 |
| 577 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 578 |
GASTROOESOPHAGEAL REFLUX DISEASE |
11 |
0.0001 |
| 579 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 580 |
MELAENA |
3 |
0.0001 |
| 581 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 582 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 583 |
OESOPHAGEAL CARCINOMA |
4 |
0.0001 |
| 584 |
FEELING DRUNK |
1 |
0.0001 |
| 585 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 586 |
PREMATURE BABY |
4 |
0.0001 |
| 587 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 588 |
ACIDOSIS |
1 |
0.0001 |
| 589 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 590 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 591 |
TENDONITIS |
2 |
0.0001 |
| 592 |
APHTHOUS ULCER |
1 |
0.0001 |
| 593 |
NICOTINE DEPENDENCE |
1 |
0.0001 |
| 594 |
RASH |
56 |
0.0001 |
| 595 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 596 |
FURUNCLE |
1 |
0.0001 |
| 597 |
PRODUCT PRESCRIBING ERROR |
3 |
0.0001 |
| 598 |
HALLUCINATION, AUDITORY |
2 |
0.0001 |
| 599 |
PREMATURE DELIVERY |
2 |
0.0001 |
| 600 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 601 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 602 |
RHINITIS |
1 |
0.0001 |
| 603 |
CONFUSIONAL STATE |
20 |
0.0001 |
| 604 |
MUSCLE DISORDER |
1 |
0.0001 |
| 605 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 606 |
BACK DISORDER |
2 |
0.0001 |
| 607 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 608 |
DECUBITUS ULCER |
1 |
0.0001 |
| 609 |
BLINDNESS |
5 |
0.0001 |
| 610 |
ENCEPHALOPATHY |
3 |
0.0001 |
| 611 |
ABNORMAL FAECES |
1 |
0.0001 |
| 612 |
CHOLELITHIASIS |
4 |
0.0001 |
| 613 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 614 |
EMBOLISM |
1 |
0.0001 |
| 615 |
FUNGAL INFECTION |
4 |
0.0001 |
| 616 |
ASTHENIA |
45 |
0.0001 |
| 617 |
LIVE BIRTH |
1 |
0.0001 |
| 618 |
HAEMODIALYSIS |
1 |
0.0001 |
| 619 |
DRUG USE DISORDER |
1 |
0.0001 |
| 620 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 621 |
THERAPY CESSATION |
6 |
0.0001 |
| 622 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
3 |
0.0001 |
| 623 |
CARDIAC OPERATION |
1 |
0.0001 |
| 624 |
ANURIA |
1 |
0.0001 |
| 625 |
PYELONEPHRITIS |
1 |
0.0001 |
| 626 |
PAIN IN EXTREMITY |
34 |
0.0001 |
| 627 |
ABDOMINAL DISTENSION |
12 |
0.0001 |
| 628 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 629 |
JOINT STIFFNESS |
3 |
0.0001 |
| 630 |
GROIN PAIN |
1 |
0.0001 |
| 631 |
LUNG INFILTRATION |
1 |
0.0001 |
| 632 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 633 |
CARDIAC FAILURE CONGESTIVE |
9 |
0.0001 |
| 634 |
THROMBOSIS |
9 |
0.0001 |
| 635 |
MYALGIA |
19 |
0.0001 |
| 636 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 637 |
HAEMARTHROSIS |
1 |
0.0001 |
| 638 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 639 |
CRYING |
4 |
0.0001 |
| 640 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 641 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 642 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 643 |
PARAESTHESIA |
17 |
0.0001 |
| 644 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 645 |
AMNESIA |
7 |
0.0001 |
| 646 |
NECK PAIN |
6 |
0.0001 |
| 647 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 648 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 649 |
ILLNESS |
11 |
0.0001 |
| 650 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 651 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 652 |
COMA |
5 |
0.0001 |
| 653 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 654 |
WEIGHT DECREASED |
29 |
0.0001 |
| 655 |
DRUG INTOLERANCE |
10 |
0.0001 |
| 656 |
HERNIA |
2 |
0.0001 |
| 657 |
ERUCTATION |
2 |
0.0001 |
| 658 |
PNEUMONIA |
33 |
0.0001 |
| 659 |
HOSPICE CARE |
1 |
0.0001 |
| 660 |
DISABILITY |
2 |
0.0001 |
| 661 |
TOXICITY TO VARIOUS AGENTS |
17 |
0.0001 |
| 662 |
ABORTION SPONTANEOUS |
4 |
0.0001 |
| 663 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 664 |
BRAIN INJURY |
1 |
0.0001 |
| 665 |
EMPHYSEMA |
1 |
0.0001 |
| 666 |
HYPOTHERMIA |
1 |
0.0001 |
| 667 |
FOETAL EXPOSURE DURING PREGNANCY |
8 |
0.0001 |
| 668 |
EYELID PTOSIS |
1 |
0.0001 |
| 669 |
FLUID RETENTION |
5 |
0.0001 |
| 670 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 671 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 672 |
THERAPY INTERRUPTED |
7 |
0.0001 |
| 673 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 674 |
PERIPHERAL SWELLING |
15 |
0.0001 |
| 675 |
HELICOBACTER INFECTION |
1 |
0.0001 |
| 676 |
GYNAECOMASTIA |
3 |
0.0001 |
| 677 |
FEMUR FRACTURE |
3 |
0.0001 |
| 678 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 679 |
EYE DISCHARGE |
1 |
0.0001 |
| 680 |
MUSCULOSKELETAL PAIN |
5 |
0.0001 |
| 681 |
ABDOMINAL DISCOMFORT |
16 |
0.0001 |
| 682 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 683 |
DYSPHAGIA |
9 |
0.0001 |
| 684 |
HALLUCINATION, VISUAL |
2 |
0.0001 |
| 685 |
PANCREATITIS |
5 |
0.0001 |
| 686 |
MIGRAINE |
9 |
0.0001 |
| 687 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 688 |
PRURITUS GENERALISED |
2 |
0.0001 |
| 689 |
ATRIAL FIBRILLATION |
9 |
0.0001 |
| 690 |
ABDOMINAL PAIN UPPER |
19 |
0.0001 |
| 691 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 692 |
SKIN LACERATION |
1 |
0.0001 |
| 693 |
ARTHRALGIA |
38 |
0.0001 |
| 694 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 695 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 696 |
DENTAL CARIES |
1 |
0.0001 |
| 697 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 698 |
TOOTH DISORDER |
2 |
0.0001 |
| 699 |
URINARY RETENTION |
3 |
0.0001 |
| 700 |
NEOPLASM MALIGNANT |
6 |
0.0001 |
| 701 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 702 |
MALNUTRITION |
1 |
0.0001 |
| 703 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 704 |
SKIN INFECTION |
1 |
0.0001 |
| 705 |
ARTHRITIS |
7 |
0.0001 |
| 706 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 707 |
ANGER |
3 |
0.0001 |
| 708 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 709 |
CONSTIPATION |
19 |
0.0001 |
| 710 |
LETHARGY |
5 |
0.0001 |
| 711 |
HYPERSENSITIVITY |
16 |
0.0001 |
| 712 |
INJURY |
6 |
0.0001 |
| 713 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 714 |
SURGERY |
5 |
0.0001 |
| 715 |
ATAXIA |
1 |
0.0001 |
| 716 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 717 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 718 |
DRY SKIN |
11 |
0.0001 |
| 719 |
SCHIZOPHRENIA |
1 |
0.0001 |
| 720 |
URINARY TRACT INFECTION |
14 |
0.0001 |
| 721 |
NASOPHARYNGITIS |
15 |
0.0001 |
| 722 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 723 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 724 |
CYST |
1 |
0.0001 |
| 725 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 726 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 727 |
DIARRHOEA |
51 |
0.0001 |
| 728 |
PRODUCT COMPLAINT |
2 |
0.0001 |
| 729 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 730 |
DEVICE DEPLOYMENT ISSUE |
1 |
0.0001 |
| 731 |
SEIZURE |
9 |
0.0001 |
| 732 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 733 |
SPEECH DISORDER |
4 |
0.0001 |
| 734 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 735 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 736 |
ADVERSE REACTION |
1 |
0.0001 |
| 737 |
SWELLING |
7 |
0.0001 |
| 738 |
CARDIAC FAILURE |
6 |
0.0001 |
| 739 |
JOINT SWELLING |
9 |
0.0001 |
| 740 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 741 |
COVID-19 |
13 |
0.0001 |
| 742 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 743 |
MOOD ALTERED |
2 |
0.0001 |
| 744 |
DEATH |
63 |
0.0001 |
| 745 |
MALAISE |
32 |
0.0001 |
| 746 |
SKIN LESION |
2 |
0.0001 |
| 747 |
MEMORY IMPAIRMENT |
10 |
0.0001 |
| 748 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
1 |
0.0001 |
| 749 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 750 |
FALL |
24 |
0.0001 |
| 751 |
ROAD TRAFFIC ACCIDENT |
3 |
0.0001 |
| 752 |
APHONIA |
1 |
0.0001 |
| 753 |
THROMBOCYTOPENIA |
8 |
0.0001 |
| 754 |
BLISTER |
4 |
0.0001 |
| 755 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 756 |
OSTEOARTHRITIS |
3 |
0.0001 |
| 757 |
PAIN IN JAW |
2 |
0.0001 |
| 758 |
HEADACHE |
44 |
0.0001 |
| 759 |
GENERAL PHYSICAL HEALTH DETERIORATION |
8 |
0.0001 |
| 760 |
HYPOKINESIA |
1 |
0.0001 |
| 761 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 762 |
ANGIOEDEMA |
3 |
0.0001 |
| 763 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 764 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 765 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 766 |
PULMONARY MASS |
1 |
0.0001 |
| 767 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 768 |
HALLUCINATION |
5 |
0.0001 |
| 769 |
HEPATIC FAILURE |
2 |
0.0001 |
| 770 |
INSURANCE ISSUE |
1 |
0.0001 |
| 771 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 772 |
HYPOKALAEMIA |
3 |
0.0001 |
| 773 |
CEREBROVASCULAR ACCIDENT |
11 |
0.0001 |
| 774 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 775 |
LYMPHOMA |
1 |
0.0001 |
| 776 |
SOMNOLENCE |
13 |
0.0001 |
| 777 |
ABDOMINAL PAIN |
15 |
0.0001 |
| 778 |
DELUSION |
1 |
0.0001 |
| 779 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 780 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 781 |
OBESITY |
1 |
0.0001 |
| 782 |
ABSCESS |
1 |
0.0001 |
| 783 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 784 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 785 |
NIGHT SWEATS |
2 |
0.0001 |
| 786 |
RHEUMATOID ARTHRITIS |
7 |
0.0001 |
| 787 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 788 |
LUNG DISORDER |
3 |
0.0001 |
| 789 |
EYE DISORDER |
2 |
0.0001 |
| 790 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 791 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 792 |
VIRAL INFECTION |
2 |
0.0001 |
| 793 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 794 |
FACE OEDEMA |
1 |
0.0001 |
| 795 |
HEMIPARESIS |
1 |
0.0001 |
| 796 |
GASTRIC DISORDER |
2 |
0.0001 |
| 797 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 798 |
PARANOIA |
1 |
0.0001 |
| 799 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 800 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 801 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 802 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 803 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 804 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 805 |
OEDEMA |
3 |
0.0001 |
| 806 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 807 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 808 |
PANIC ATTACK |
2 |
0.0001 |
| 809 |
RESTLESSNESS |
2 |
0.0001 |
| 810 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 811 |
AGITATION |
4 |
0.0001 |
| 812 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
11 |
0.0001 |
| 813 |
FEELING ABNORMAL |
13 |
0.0001 |
| 814 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 815 |
PANCYTOPENIA |
3 |
0.0001 |
| 816 |
HYPONATRAEMIA |
3 |
0.0001 |
| 817 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 818 |
MUSCULAR WEAKNESS |
6 |
0.0001 |
| 819 |
COLITIS |
2 |
0.0001 |
| 820 |
GASTRIC ULCER |
1 |
0.0001 |
| 821 |
BLOOD PRESSURE INCREASED |
8 |
0.0001 |
| 822 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 823 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 824 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 825 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 826 |
NAUSEA |
41 |
0.0001 |
| 827 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 828 |
CHOKING |
1 |
0.0001 |
| 829 |
KIDNEY INFECTION |
1 |
0.0001 |
| 830 |
SINUS DISORDER |
1 |
0.0001 |
| 831 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 832 |
CATARACT |
3 |
0.0001 |
| 833 |
SYNCOPE |
5 |
0.0000 |
| 834 |
SUICIDE ATTEMPT |
3 |
0.0000 |
| 835 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 836 |
FEEDING DISORDER |
1 |
0.0000 |
| 837 |
FEELING HOT |
3 |
0.0000 |
| 838 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 839 |
INFECTION |
7 |
0.0000 |
| 840 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 841 |
DERMATITIS |
1 |
0.0000 |
| 842 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 843 |
EATING DISORDER |
1 |
0.0000 |
| 844 |
PRURITUS |
18 |
0.0000 |
| 845 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 846 |
SKIN CANCER |
1 |
0.0000 |
| 847 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 848 |
INFUSION RELATED REACTION |
3 |
0.0000 |
| 849 |
INFLUENZA |
5 |
0.0000 |
| 850 |
ORAL PAIN |
1 |
0.0000 |
| 851 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 852 |
RASH PAPULAR |
1 |
0.0000 |
| 853 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 854 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
8 |
0.0000 |
| 855 |
CHROMATURIA |
1 |
0.0000 |
| 856 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 857 |
ASTHMA |
5 |
0.0000 |
| 858 |
DYSPNOEA |
25 |
0.0000 |
| 859 |
INJECTION SITE REACTION |
3 |
0.0000 |
| 860 |
SHOCK |
1 |
0.0000 |
| 861 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 862 |
DECREASED APPETITE |
10 |
0.0000 |
| 863 |
COUGH |
12 |
0.0000 |
| 864 |
ARRHYTHMIA |
2 |
0.0000 |
| 865 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 866 |
URTICARIA |
7 |
0.0000 |
| 867 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 868 |
LOCALISED INFECTION |
1 |
0.0000 |
| 869 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 870 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 871 |
PRESYNCOPE |
1 |
0.0000 |
| 872 |
UNDERDOSE |
3 |
0.0000 |
| 873 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 874 |
CELLULITIS |
2 |
0.0000 |
| 875 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 876 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 877 |
ACNE |
3 |
0.0000 |
| 878 |
GASTRIC CANCER |
1 |
0.0000 |
| 879 |
HAEMATEMESIS |
1 |
0.0000 |
| 880 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 881 |
FLUSHING |
4 |
0.0000 |
| 882 |
HEPATITIS |
1 |
0.0000 |
| 883 |
OFF LABEL USE |
34 |
0.0000 |
| 884 |
HYPERHIDROSIS |
5 |
0.0000 |
| 885 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 886 |
PSORIASIS |
5 |
0.0000 |
| 887 |
NERVOUSNESS |
2 |
0.0000 |
| 888 |
SEDATION |
1 |
0.0000 |
| 889 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 890 |
DEPRESSED MOOD |
2 |
0.0000 |
| 891 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 892 |
JAUNDICE |
1 |
0.0000 |
| 893 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 894 |
RASH PRURITIC |
2 |
0.0000 |
| 895 |
PALLOR |
1 |
0.0000 |
| 896 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 897 |
ARTHROPATHY |
2 |
0.0000 |
| 898 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 899 |
SEPSIS |
4 |
0.0000 |
| 900 |
INJECTION SITE PAIN |
11 |
0.0000 |
| 901 |
DRUG INEFFECTIVE |
47 |
0.0000 |
| 902 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 903 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 904 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 905 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 906 |
PALPITATIONS |
4 |
0.0000 |
| 907 |
ERYTHEMA |
7 |
0.0000 |
| 908 |
ASCITES |
1 |
0.0000 |
| 909 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 910 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 911 |
TACHYCARDIA |
3 |
0.0000 |
| 912 |
IRRITABILITY |
2 |
0.0000 |
| 913 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 914 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 915 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 916 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 917 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 918 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 919 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 920 |
BLOOD GLUCOSE INCREASED |
6 |
0.0000 |
| 921 |
PYREXIA |
11 |
0.0000 |
| 922 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 923 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 924 |
SWELLING FACE |
2 |
0.0000 |
| 925 |
TREMOR |
5 |
0.0000 |
| 926 |
DIZZINESS |
15 |
0.0000 |
| 927 |
LIP SWELLING |
1 |
0.0000 |
| 928 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 929 |
RASH MACULAR |
1 |
0.0000 |
| 930 |
SLEEP DISORDER |
2 |
0.0000 |
| 931 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 932 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 933 |
BRONCHITIS |
2 |
0.0000 |
| 934 |
EYE SWELLING |
1 |
0.0000 |
| 935 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 936 |
DISORIENTATION |
1 |
0.0000 |
| 937 |
PROSTATE CANCER |
2 |
0.0000 |
| 938 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 939 |
CARDIAC ARREST |
2 |
0.0000 |
| 940 |
PRODUCT USE IN UNAPPROVED INDICATION |
6 |
0.0000 |
| 941 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 942 |
HYPOACUSIS |
1 |
0.0000 |
| 943 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 944 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 945 |
DEHYDRATION |
3 |
0.0000 |
| 946 |
SKIN IRRITATION |
1 |
0.0000 |
| 947 |
ADVERSE EVENT |
2 |
0.0000 |
| 948 |
BREAST CANCER |
2 |
0.0000 |
| 949 |
CARDIAC DISORDER |
2 |
0.0000 |
| 950 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 951 |
RENAL CANCER |
1 |
0.0000 |
| 952 |
COLORECTAL CANCER |
1 |
0.0000 |
| 953 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 954 |
CONTUSION |
2 |
0.0000 |
| 955 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 956 |
ALOPECIA |
4 |
0.0000 |
| 957 |
AGGRESSION |
1 |
0.0000 |
| 958 |
HYPOTENSION |
4 |
0.0000 |
| 959 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 960 |
INFLAMMATION |
1 |
0.0000 |
| 961 |
ECZEMA |
1 |
0.0000 |
| 962 |
OVERDOSE |
4 |
0.0000 |
| 963 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 964 |
DYSPHONIA |
1 |
0.0000 |
| 965 |
CHILLS |
2 |
0.0000 |
| 966 |
NASAL CONGESTION |
1 |
0.0000 |
| 967 |
VOMITING |
8 |
0.0000 |
| 968 |
DISCOMFORT |
1 |
0.0000 |
| 969 |
CHEST PAIN |
3 |
0.0000 |
| 970 |
RHINORRHOEA |
1 |
0.0000 |
| 971 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 972 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 973 |
NEUTROPENIA |
2 |
0.0000 |
| 974 |
VISION BLURRED |
2 |
0.0000 |
| 975 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 976 |
DYSGEUSIA |
1 |
0.0000 |
| 977 |
EPISTAXIS |
1 |
0.0000 |
| 978 |
HOT FLUSH |
1 |
0.0000 |
| 979 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 980 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 981 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 982 |
DRY MOUTH |
1 |
0.0000 |
| 983 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 984 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 985 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 986 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 987 |
HEART RATE INCREASED |
1 |
0.0000 |
| 988 |
SINUSITIS |
1 |
0.0000 |
| 989 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 990 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 991 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |